EIR Teva Parenteral Manufacturing Feb 2010

John Gonzalez FDA, Dyana Stone FDA$595.00 - Available Now

FDA investigators audited the Teva Parenteral Manufacturing - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 01 Feb 2010.

Product details

  • Category:
  • Inspection end: 01 Feb 2010
  • Location: Irvine, United States
  • FEI: 2027158
Add To Cart